“Vibrant presenters and perspectives!” —CMO, PURDUE PHARMA

“Very important coverage of strategic partnerships.” —Senior Manager, SAMSUNG BIOEPIS

The FierceBiotech Drug Development Forum is coming back to Boston this fall! This event is an unequaled networking and strategy-setting forum, where biotech executives gather to optimize their partnership portfolios, secure investors, achieve best-in-breed status, and improve early research results.

Last year’s conference featured over 300 attendees, with 120 speakers — 90% of whom at the VP or C-suite levels. Register today to join us on October 1–3, 2018, to guide your companies towards the best partnerships for drug development!

TOPICS WILL INCLUDE:

• Adding orphan indications to accelerate development
• Updating collaboration models between biotech and big pharma
• Working with new, non-traditional biotech investors, including foreign banks and sovereign wealth funds
• Responding to cyber attacks
• Taking advantage of new growth areas after Trump’s tax reforms
• Breaking through a crowded market in immuno-oncology
• Setting proper value for digital therapeutics
• Forming academic partnerships best for early clinical research
• Withstanding the next market downturn
• Advancing deals with investors left concerned by prior failures
• Negotiating co-commercialization deals
• Facing the disruption of the traditional PBM model

...and more!

INTERESTED IN PARTICIPATING?

There are still opportunities to join this year’s agenda! For information on speaking, please contact Matt Greenbaum at 212-400-6242 or mgreenbaum@exlevents.com. For sponsorship and exhibition opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com.

We look forward to seeing you this October — along with hundreds of key decision-makers in biotech!

Sincerely,

Matt Greenbaum
Production Team Leader, ExL Events